On Twitter, BioCubaFarma -dedicated to the development of these formulations, announced that Carla Vizzoti found out about the results of Soberana 02 and Abdala, the two candidates that are currently under phase III of clinical trials.

Accompanied by Presidential Advisor Cecilia Nicolini and Ambassador to Cuba Luis Alberto Larregui, Vizzoti learned about 20-year collaboration between the Cuban biopharmaceutical sector and Argentine institutions.

‘We are in Havana to learn from the Cuban health authorities and scientists about progress of Abdala and Soberana 02 vaccine candidates,’ Vizzotti tweeted.

Vizzotti highlighted that her delegation came from Mexico, where regional ties and strategies were strengthened and with great pride and joy Presidents Alberto Fernández and Andrés Manuel López Obrador announced the beginning of AstraZeneca vaccine distribution.

ef/pll/mem/alb